Nu Skin (NUS) Q3 2026 Earnings Report

The call presented meaningful progress in Prysm adoption, Rhyz performance, sales-leader development, India preparation, cost restructuring, and balance-sheet management. However, these positives were balanced by ongoing core-business pressure, weaker gross and operating margins, foreign-currency headwinds, transition costs, and negative full-year reported EPS guidance. Management remained constructive about the strategic initiatives and long-term outlook, but the near-term financial picture was mixed.

For the fourth quarter, Nu Skin expects revenue in the range of $310 million-$340 million, including an anticipated foreign currency tailwind of approximately 1%, reported earnings per share in the range of $0.05-$0.15, and adjusted earnings per share of $0.11-$0.21; it currently anticipates approximately $5 million in remaining cash-based organizational transition costs in the fourth quarter, which have been excluded from its adjusted earnings guidance. For the full year, it now expects revenue of $1.26 billion-$1.29 billion, including an anticipated foreign currency headwind of approximately 1%, annual reported earnings per share of negative $5.08 to negative $4.98, and adjusted annual earnings per share of $0.55-$0.65, excluding these non-cash items, certain other year-to-date charges, and anticipated fourth quarter organizational transition costs; after these adjustments, its guidance reflects an effective tax rate for the year of approximately 39%.